Atillasoy Ercem
Known title: See RemarksCIK: 0001818802
Associated companies
Transaction History
| KLRS | ▼ Sell | Open Market | 1,527 | $13K | 10/20/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 568 | $5K | 10/19/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 1,533 | $8K | 7/21/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 563 | $3K | 7/20/2022 | View on chart |
| KLRS | ▲ Buy | Grant | 14,000 | $0 | 7/1/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 1,587 | $9K | 4/21/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 453 | $3K | 4/20/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 4,639 | $38K | 1/25/2022 | View on chart |
| KLRS | ▲ Buy | Grant | 23,256 | $0 | 1/18/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 1,514 | $37K | 10/21/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Kalaris Therapeutics Moves in Pre-Market Amid Low RSI
Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.
Kalaris Therapeutics Moves in Pre-Market Amid Low RSI. Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.